eCARTv5 Clinical Deterioration Suite (“eCART”) vs SymptomScreen

SymptomScreen is designed for non-clinical users and emphasizes ease of use, quick screening times (average 17 seconds), and the ability to accept non-medical language and misspellings. This focus on simplifying the process for a broader user base gives it an edge in usability. eCARTv5, while integrated into EHRs, is a clinical decision support tool for healthcare professionals and its usability would be judged on different, more complex criteria.

eCARTv5 is an FDA-cleared AI-powered Software as a Medical Device (SaMD) that continuously assesses and predicts the risk of clinical deterioration in hospitalized adult patients. It has undergone extensive retrospective and prospective validation, outperforming other early warning scores in identifying clinical deterioration. SymptomScreen, while valuable for call prioritization, is designed for non-clinical users and focuses on consistent call routing rather than direct clinical prediction or intervention.

SymptomScreen offers transparent monthly and annual pricing options, including volume discounts and a 50% discount for certain healthcare facilities, with no setup fees or hidden charges. This clear and accessible pricing structure, along with a free trial, provides better value transparency. eCARTv5 requires prospective customers to contact the vendor for a tailored quote, making its pricing and overall value less transparent upfront.

eCARTv5 is designed for seamless integration with Electronic Health Record (EHR) systems and is deployed at scale in hundreds of hospitals, with over 4.4 million patient encounters. It is SOC-II and HIPAA compliant, indicating robust security and readiness for large-scale enterprise deployment. SymptomScreen also integrates with EHR/EMR/CRM systems and offers enterprise pricing for 100+ subscriptions, but eCARTv5's proven extensive deployment and FDA clearance for a critical function demonstrate a higher level of enterprise readiness for complex clinical environments.

eCARTv5 leverages AI and machine learning to provide continuous, real-time prediction of clinical deterioration, integrating up to 97 variables from EHRs and guiding care with embedded clinical pathways. This represents a significant advancement in proactive patient management. SymptomScreen innovates by replacing outdated 'red flag' lists with physician-authored guides for non-clinical staff, but its core function is call prioritization rather than advanced predictive analytics.

Both tools offer documentation and support. SymptomScreen provides FAQs, guides, and manuals, and emphasizes customer support. AgileMD, with eCARTv5, has a strong publication record and likely offers comprehensive support given its complex clinical application and enterprise-level deployment. Without specific comparative details on the breadth and accessibility of their support and documentation, it's difficult to definitively pick a winner.